A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
Altor BioScience
Altor BioScience
University of Vermont
Leap Therapeutics, Inc.
Nektar Therapeutics
Barbara Ann Karmanos Cancer Institute
Vanderbilt-Ingram Cancer Center
Masonic Cancer Center, University of Minnesota
Rigshospitalet, Denmark
H. Lee Moffitt Cancer Center and Research Institute
Attenuon